Medical Research Council (MRC)
Welcome,         Profile    Billing    Logout  
 3 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
D'Alessandro, Umberto
NCT05974267: Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)

Recruiting
2
192
RoW
M5717 60 mg, Pyronaridine, Pyronaridine tetraphosphate, Atovaquone-Proguanil, M5717 200 mg, M5717 660mg
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Malaria Infection
04/24
04/24
NCT05357560: A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21

Recruiting
1
96
RoW
Matrix-M with RH5.2 VLP and/or R21
University of Oxford, European and Developing Countries Clinical Trials Partnership (EDCTP), Medical Research Council Unit The Gambia at the LSHTM (MRCG)
Malaria, Plasmodium Falciparum
07/25
07/25
INDIE-1b, NCT04053907: P. Falciparum Infection Dynamics and Transmission to Inform Elimination

Recruiting
N/A
4000
RoW
Community Case Management, Weekly fever screening and treatment, Monthly malaria screening, MDA
London School of Hygiene and Tropical Medicine, Medical Research Council Unit, The Gambia, National Malaria Control Programme, The Gambia, Radboud University Medical Center, University of California, San Francisco, Institute for Disease Modeling
Malaria
05/22
05/22

Download Options